This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundIn recent years, the relationship between periodontal disease (PD) and atherosclerosis (AS) has garnered significant scholarly attention. Keyword analysis reveals “atherosclerosis,” “periodontal disease,” “cardiovascular disease,” “Porphyromonas gingivalis,” and “periodontal pathogens” as research hotspots.
As the yearly conference of the Heart Failure Association of the ESC, its overarching goal is to enhance the quality of life and extend longevity by advancing prevention, diagnosis, and treatment of heart failure. EAS Congress explores the latest research developments into the causes of atherosclerosis and related vascular disease.
As the yearly conference of the Heart Failure Association of the ESC, its overarching goal is to enhance the quality of life and extend longevity by advancing prevention, diagnosis, and treatment of heart failure. EAS Congress explores the latest research developments into the causes of atherosclerosis and related vascular disease.
PAD is a serious, progressive cardiovascular disease primarily caused by a buildup of fatty plaque in the blood vessels, or atherosclerosis. This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life.
Identifying new targeted therapeutic approaches has become a priority of biomedical research to improve patient outcomes and quality of life. Cardiovascular disease (CVD) represents the leading cause of mortality and disability all over the world.
Hutchinson-Gilford Progeria Syndrome (HGPS) is an ultra-rare genetic premature aging disease that is historically fatal in teenage years, secondary to severe accelerated atherosclerosis. years by 4.3 years (30%).
The European Heart Rhythm Association (EHRA) is a branch of the European Society of Cardiology (ESC), which aims to improve patients’ quality of life and reduce sudden cardiac death by limiting the impact of heart rhythm disturbances. More information: www.escardio.org References and notes 1 Tzeis S, Gerstenfeld EP, Kalman J, et al.
Patients with obstructive hypertrophic cardiomyopathy who underwent surgical myectomy reported improved quality of life. The American Heart Association draws attention to nonalcoholic fatty liver disease, which affects about one in four adults and is a risk factor for atherosclerotic cardiovascular disease.
By prioritizing cardiovascular health, individuals can improve their quality of life and longevity. Moreover, a healthy heart contributes to improved overall fitness, endurance, and quality of life. This process, known as atherosclerosis, increases the risk of heart disease, heart attacks, and strokes.
Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life. This blog post explores the development of such partnerships and their potential to transform healthcare outcomes. Here are four key strategies to achieve this: 1.Shared
A stroke is often a devastating occurrence for several reasons: A stroke can be life threatening and stroke is widely recognised as a leading cause of death worldwide A stroke can be disabling and can destroy a person’s quality of life A stroke can recur and cause more damage/death the next time.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Among patients with heart failure (HF), fatigue is common and linked to quality of life and functional status. Fatigue is hypothesized to manifest as multiple types, with general and exertional components.
What better way to join the fall festivities than by spotlighting key insights in cardiorenal metabolic medicine, primary prevention, and quality of life improvements shared at this year’s biggest U.S. cardiometabolic health CME/CE conference: the 19th Annual CMHC.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content